In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...

This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...

RNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial. However, the speed of vaccine production is ...

The COVID-19 pandemic thrust messenger RNA (mRNA) into the spotlight, underscoring its promise as a nimble, programmable platform for delivering genetic instructions directly to cells. The success of ...

Expanding Africa’s capacity to produce mRNA vaccines has reached a new milestone with BioNTech’s opening of a facility in Kigali, Rwanda. This facility is designated for manufacturing vaccines for use ...

SEOUL, South Korea--(BUSINESS WIRE)--Lemonex Inc., a biotechnology company developing innovative messenger RNA (mRNA) and siRNA therapeutics based on a novel nanoparticle drug delivery system ...

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, ...

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between ...